North America Artificial Tears Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Cellulose Derived Tears, Glycerin Derived Tears, Oil-based Emulsion Tears, Polythylene Glycol Based Tears, Propylene Glycol Based Tears, and Sodium Hyaluronate Based Artificial Tears); Delivery Mode (Eye Drops, and Ointments); Application (Dry Eyes Treatment, and Contact Lenses Moisture)

TIPRE00023484 | Pages: 122 | Pharmaceuticals | Jul 2021 | Type: Regional | Status: Published

Market Introduction

Artificial tears are lubricant eye drops used for treating the irritation and dryness associated with the deficiency in tear production in dry eyes or keratoconjunctivitis sicca. These are also used for moistening contact lenses and during eye check-ups and examinations. The rapidly growing aging population is primarily contributing to the growth of the artificial tears market. Aging makes people more susceptible to eye conditions such as dry eye, resulting in high demand for artificial tears. Also, increasing number of eye surgeries and post eye surgery management is further boosting the growth of the artificial tears market.

Thus, a growing older population is expected to create a significant demand for artificial tears in the coming years, which is further anticipated to drive the artificial tears market.

Several measures are being taken to treat the disease and prevent transmission; however, the exorbitant number of COVID- 19 cases has resulted in the cancellation of the doctor's appointment. With COVID-19 continuing to spread all over the world, researchers are looking into numerous options for possible treatment, including existing options. In July 2020, Alcon, the global leader in eye care dedicated to helping people see brilliantly, announced the findings of a new survey, coincide with Dry Eye Awareness Month. The survey of 1,005 nationally representative U.S. adults, conducted by research firm Ipsos, reveals the influence of the COVID-19 pandemic on consumers' screen time and how it affects their perceptions of eye health. According to the survey Nearly 80% of Americans reported their screen time increased during the COVID-19 pandemic. Three out of five (60%) people who have increased their screen time are concerned about the impact on their eyes. Nearly half (45%) of individuals who spend more time in front of the screen say it makes their eyes dry. These factors had a potential impact on the North America artificial tears market.

 

 


Get more information on this report :



Market Overview and Dynamics

The Artificial tears market in North America is expected to grow from US$ 1,672.6 million in 2021 to US$ 2,392.8 million by 2028; it is estimated to grow at a CAGR of 5.2% from 2021 to 2028. The industry is witnessing a considerable number of business activities that are generating a very lucrative growth opportunity for the market. The players in the industry are focusing on brand establishments, as well as consolidation of supply chain distribution channels with an aim to leverage their presence in the global market. For instance, in March 2020, Grafton Optical launched I-DROP MGD Viscoadaptive Tears that provide the relief for severe chronic evaporative dry eye. I-DROP MGD is preservative-free, artificial tear that helps relieve symptoms associated with evaporative dry eye, for patients suffering from Meibomian Gland Dysfunction. It is the most advanced eye drop for hydrating and lubricating the cornea. In addition, the companies are working proactively to launch advanced products in the market. For instance, in March 2020, Alcon, the global leader in eye care introduced SYSTANE HYDRATION Preservative-Free (PF) Lubricant Eye Drops for dry eye. It is used to relieve dryness of the eye and as a protectant against further irritation. Further, in October 2019, Allergan launched a new product line called Refresh Relieva lubricant eye. The launch of the novel product has helped the company retain its position in the eye drop industry. Such strategic events are likely to offer lucrative growth opportunity for the artificial tears market during the forecast period.

 

Key Market Segments

In terms of type, the glycerin derived tears segment accounted for the largest share of the North America artificial tears market in 2020. In terms of delivery mode, the eye drops segment accounted for the largest share of the North America artificial tears market in 2020. In terms of application, the dry eyes treatment segment held a larger market share of the artificial tears market in 2020.

 

Major Sources and Companies Listed

A few major primary and secondary sources referred to for preparing this report on the Artificial tears market in North America are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Johnson and Johnson Services, Inc., Alcon Inc., OASIS Medical, AbbVie Inc., Bayer AG, Prestige Consumer Healthcare Inc., Santen Pharmaceutical Co., Ltd., Bausch Health Companies Inc., and Akorn, Incorporated.

 

Reasons to buy report

  • To understand the North America Artificial tears market landscape and identify market segments that are most likely to guarantee a strong return
  • Stay ahead of the race by comprehending the ever-changing competitive landscape for North America Artificial tears market
  • Efficiently plan M&A and partnership deals in North America Artificial tears market by identifying market segments with the most promising probable sales
  • Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form North America Artificial tears market
  • Obtain market revenue forecast for market by various segments from 2021-2028 in North America region.

 

NORTH AMERICA ARTIFICIAL TEARS MARKET SEGMENTATION

By Type

  • Glycerin Derived Tears
  • Cellulose Derived Tears
  • Oil-based Emulsion Tears
  • Polythylene Glycol Based Tears
  • Sodium Hyaluronate Based Artificial Tears
  • Propylene Glycol Based Tears

 

By Delivery Mode

  • Eye Drops
  • Ointments

 

 

By Application

  • Dry Eyes Treatment
  • Contact Lenses Moisture

 

By Country

  • North America
    • US
    • Canada
    • Mexico

 

Companies Mentioned

  1. Johnson and Johnson Services, Inc.
  2. Alcon Inc.
  3. OASIS Medical
  4. AbbVie Inc.
  5. Bayer AG
  6. Prestige Consumer Healthcare Inc.
  7. Santen Pharmaceutical Co., Ltd.
  8. Bausch Health Companies Inc.
  9. Akorn, Incorporated

 

1.           Introduction

1.1          Scope of the Study

1.2          The Insight Partners Research Report Guidance

1.3          Market Segmentation

1.3.1          Artificial Tears Market – By Type

1.3.2          Artificial Tears Market – By Delivery Mode

1.3.3          Artificial Tears Market – By Application

1.3.4          North America Artificial tears Market – By Country

2.           North America Artificial Tears Market – Key Takeaways

3.           Research Methodology

3.1          Coverage

3.2          Secondary Research

3.3          Primary Research

4.           North America Artificial Tears Market – Market Landscape

4.1          Overview

4.2          PEST Analysis

4.2.1          Artificial Tears Market- North America PEST Analysis

4.3          Expert Opinion

5.           North America Artificial Tears Market - Key Market Dynamics

5.1          Market Drivers

5.1.1          Rising Incidence of Dry Eye

5.1.2          Growing Older Population

5.2          Market Restraints

5.2.1          Poor Accessibility to Eye Care Services in Countries

5.3          Market Opportunities

5.3.1          Increasing Number of Industrial Developments

5.4          Future Trends

5.4.1          Changes in Lifestyle

5.5          Impact Analysis

6.           Artificial Tears Market – North America Analysis

6.1          North America Artificial Tears Market Revenue Forecasts and Analysis

7.           North America Artificial Tears Market Analysis and Forecasts To 2028 – By Type

7.1          Overview

7.2          Artificial Tears Market Revenue Share, by Type (2020 and 2028)

7.3          Cellulose Derived Tears

7.3.1          Overview

7.3.2          Cellulose Derived Tears: Artificial Tears Market – Revenue and Forecast to 2028 (US$ Million)

7.4          Glycerin Derived Tears

7.4.1          Overview

7.4.2          Glycerin Derived Tears: Artificial Tears Market – Revenue and Forecast to 2028 (US$ Million)

7.5          Oil-based Emulsion Tears

7.5.1          Overview

7.5.2          Oil-based Emulsion Tears: Artificial Tears Market – Revenue and Forecast to 2028 (US$ Million)

7.6          Polyethylene Glycol Based Tears

7.6.1          Overview

7.6.2          Polyethylene Glycol Based Tears: Artificial Tears Market – Revenue and Forecast to 2028 (US$ Million)

7.7          Propylene Glycol Based Tears

7.7.1          Overview

7.7.2          Propylene Glycol Based Tears: Artificial Tears Market – Revenue and Forecast to 2028 (US$ Million)

7.8          Sodium Hyaluronate Based Artificial Tears

7.8.1          Overview

7.8.2          Sodium Hyaluronate Based Artificial Tears: Artificial Tears Market – Revenue and Forecast to 2028 (US$ Million)

8.           North America Artificial Tears Market Analysis and Forecasts To 2028 – By Delivery Mode

8.1          Overview

8.2          Artificial Tears Market Revenue Share, by Delivery Mode (2020 and 2028)

8.3          Eye Drops

8.3.1          Overview

8.3.2          Eye Drops: Artificial Tears Market – Revenue and Forecast to 2028 (US$ Million)

8.4          Ointments

8.4.1          Overview

8.4.2          Ointments: Artificial Tears Market – Revenue and Forecast to 2028 (US$ Million)

9.           North America Artificial Tears Market Analysis and Forecasts to 2028– By Application

9.1          Overview

9.2          Artificial Tears Market Share, by Application, 2020 and 2028, (%)

9.3          Dry Eyes Treatment

9.3.1          Overview

9.3.2          Dry Eyes Treatment: Artificial Tears Market – Revenue and Forecast to 2028 (US$ Million)

9.4          Contact Lenses Moisture

9.4.1          Overview

9.4.2          Contact Lenses Moisture: Artificial Tears Market – Revenue and Forecast to 2028 (US$ Million)

10.        Artificial Tears Market Revenue and Forecasts to 2028 – Geographical Analysis

10.1        North America: Artificial Tears Market

10.1.1        Overview

10.1.2        North America: Artificial Tears Market, by Country, 2020 & 2028 (%)

10.1.2.1          US: Artificial Tears Market– Revenue and Forecast to 2028 (USD Million)

10.1.2.1.1           US: Artificial Tears Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.1.2           US: Artificial Tears Market, by Type, 2019–2028 (USD Million)

10.1.2.1.3           US: Artificial Tears Market, by Delivery Mode, 2019–2028 (USD Million)

10.1.2.1.4           US: Artificial Tears Market, by Application, 2019–2028 (USD Million)

10.1.2.2          Canada: Artificial Tears Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.1           Canada: Artificial Tears Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.2.2           Canada: Artificial Tears Market, by Type, 2019–2028 (USD Million)

10.1.2.2.3           Canada: Artificial Tears Market, by Delivery Mode, 2019–2028 (USD Million)

10.1.2.2.4           Canada: Artificial Tears Market, by Application, 2019–2028 (USD Million)

10.1.2.3          Mexico: Artificial Tears Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.1           Mexico: Artificial Tears Market – Revenue and Forecast to 2028 (USD Million)

10.1.2.3.2           Mexico Artificial Tears Market, by Type – 2019–2028 (USD Million)

10.1.2.3.3           Mexico Artificial Tears Market, by Delivery Mode – 2019–2028 (USD Million)

10.1.2.3.4           Mexico Artificial Tears Market, by Application – 2019–2028 (USD Million)

11.        Impact Of COVID-19 Pandemic on North America Artificial Tears Market

11.1        North America: Impact Assessment of COVID-19 Pandemic

12.        Industry Landscape

12.1        Overview

12.2        Growth Strategies Done by the Companies in the Market, (%)

12.3        Organic Developments

12.3.1        Overview

12.4        Inorganic Developments

12.4.1        Overview

13.        COMPANY PROFILES

13.1        Johnson and Johnson Services, Inc.

13.1.1        Key Facts

13.1.2        Business Description

13.1.3        Products and Services

13.1.4        Financial Overview

13.1.5        SWOT Analysis

13.1.6        Key Developments

13.2        Alcon Inc.

13.2.1        Key Facts

13.2.2        Business Description

13.2.3        Products and Services

13.2.4        Financial Overview

13.2.5        SWOT Analysis

13.2.6        Key Developments

13.3        OASIS Medical

13.3.1        Key Facts

13.3.2        Business Description

13.3.3        Products and Services

13.3.4        Financial Overview

13.3.5        SWOT Analysis

13.3.6        Key Developments

13.4        Abbvie Inc.

13.4.1        Key Facts

13.4.2        Business Description

13.4.3        Products and Services

13.4.4        Financial Overview

13.4.5        SWOT Analysis

13.4.6        Key Developments

13.5        Bayer AG

13.5.1        Key Facts

13.5.2        Business Description

13.5.3        Products and Services

13.5.4        Financial Overview

13.5.5        SWOT Analysis

13.5.6        Key Developments

13.6        Prestige Consumer Healthcare Inc.

13.6.1        Key Facts

13.6.2        Business Description

13.6.3        Products and Services

13.6.4        Financial Overview

13.6.5        SWOT Analysis

13.6.6        Key Developments

13.7        Santen Pharmaceutical Co., Ltd.

13.7.1        Key Facts

13.7.2        Business Description

13.7.3        Products and Services

13.7.4        Financial Overview

13.7.5        SWOT Analysis

13.7.6        Key Developments

13.8        Bausch Health Companies Inc.

13.8.1        Key Facts

13.8.2        Business Description

13.8.3        Products and Services

13.8.4        Financial Overview

13.8.5        SWOT Analysis

13.8.6        Key Developments

13.9        Akorn, Incorporated

13.9.1        Key Facts

13.9.2        Business Description

13.9.3        Products and Services

13.9.4        Financial Overview

13.9.5        SWOT Analysis

13.9.6        Key Developments

14.        Appendix

14.1        About the Insight Partners

14.2        Glossary of Terms

 

LIST OF TABLES

Table 1.              US Artificial Tears Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 2.              US Artificial Tears Market, by Delivery Mode – Revenue and Forecast to 2028 (USD Million)

Table 3.              US Artificial Tears Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 4.              Canada Artificial Tears Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 5.              Canada Artificial Tears Market, by Delivery Mode – Revenue and Forecast to 2028 (USD Million)

Table 6.              Canada Artificial Tears Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 7.              Mexico Artificial Tears Market, by Type– Revenue and Forecast to 2028 (USD Million)

Table 8.              Mexico Artificial Tears Market, by Delivery Mode – Revenue and Forecast to 2028 (USD Million)

Table 9.              Mexico Artificial Tears Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 10.            Organic Developments Done by Companies

Table 11.            Inorganic Developments Done by Companies

Table 12.            Glossary of Terms, Artificial Tears Market

 

LIST OF FIGURES

Figure 1.            Artificial Tears Market Segmentation

Figure 2.            North America Artificial Tears Market Overview

Figure 3.            Glycerin Derived Tears Segment Held Largest Share of Type in Artificial Tears Market

Figure 4.            US is Expected to Show Remarkable Growth During the Forecast Period

Figure 5.            Artificial Tears Market - North America PEST Analysis

Figure 6.            Artificial Tears Market Impact Analysis of Driver and Restraints

Figure 7.            North America Artificial Tears Market – Revenue Forecasts and Analysis – 2020- 2028

Figure 8.            Artificial Tears Market Revenue Share, by Type (2020 and 2028)

Figure 9.            Cellulose Derived Tears: Artificial Tears Market – Revenue and Forecast to 2028 (US$ Million)

Figure 10.          Glycerin Derived Tears: Artificial Tears Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11.          Oil-based Emulsion Tears: Artificial Tears Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12.          Polyethylene Glycol Based Tears: Artificial Tears Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.          Propylene Glycol Based Tears: Artificial Tears Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.          Sodium Hyaluronate Based Artificial Tears: Artificial Tears Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15.          Artificial Tears Market Revenue Share, by Delivery Mode (2020 and 2028)

Figure 16.          Eye Drops: Artificial Tears Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.          Ointments: Artificial Tears Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18.          Artificial Tears Market Share, by Application, 2020 and 2028 (%)

Figure 19.          Dry Eyes Treatment: Artificial Tears Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20.          Contact Lenses Moisture: Artificial Tears Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.          North America: Artificial Tears Market, by Key Country – Revenue (2020) (USD Million)

Figure 22.          North America: Artificial Tears Market, by Country, 2020 & 2028 (%)

Figure 23.          US: Artificial Tears Market – Revenue and Forecast to 2028 (USD Million)

Figure 24.          Canada: Artificial Tears Market – Revenue and Forecast to 2028 (USD Million)

Figure 25.          Mexico: Artificial Tears Market – Revenue and Forecast to 2028 (USD Million)

Figure 26.          Impact of COVID-19 Pandemic in North American Country Markets

Figure 27.          Growth Strategies Done by the Companies in the Market, (%)

 

 

  1. Johnson and Johnson Services, Inc.
  2. Alcon Inc.
  3. OASIS Medical
  4. AbbVie Inc.
  5. Bayer AG
  6. Prestige Consumer Healthcare Inc.
  7. Santen Pharmaceutical Co., Ltd.
  8. Bausch Health Companies Inc.
  9. Akorn, Incorporated
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America artificial tears market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the North America artificial tears market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth North America market trends and outlook coupled with the factors driving the artificial tears market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
$1800
Site License
$4000
$2400
Enterprise License
$5000
$3000